Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
An anatomical site is defined as a specific part, region, or location within the body, such as an organ, tissue, or limb (National Cancer Institute, 2024). It serves as a descriptive category in medical coding, pathology, and clinical trials to specify where a disease is located or where a therapeutic intervention is applied. Unlike therapeutic targets such as receptors, enzymes, or transporters, an anatomical site is a macro-scale physical structure and does not possess a specific molecular sequence or biochemical function that can be directly modulated by a drug. Because it represents a physical space rather than a functional biological molecule, it does not have associated molecular classifications, signaling pathways, or direct drug-binding mechanisms. Consequently, this term is considered an incorrect entry for a database of molecular therapeutic targets and is instead used for topographical classification (MeSH, 2024).
Not applicable as this term refers to a physical location rather than a molecular entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Anatomical site.